Individual characterisation of the metastatic capacity of human breast carcinoma (Q34013792)

30 July 2017

1 reference

title

Individual characterisation of the metastatic capacity of human breast carcinoma (English)

1 reference

30 July 2017

Heimann R

1 reference

30 July 2017

Hellman S

series ordinal

1 reference

30 July 2017

language of work or name

1 reference

1 August 2000

1 reference

European Journal of Cancer

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

issue

13 Spec No

1 reference

30 July 2017

page(s)

1631-1639

1 reference

30 July 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

American Joint Committee on Cancer prognostic factors consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Staging of breast cancer and survival rates. An assessment based on 50 years of experience with radical mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Dormancy of mammary carcinoma after mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

I. The Results of Radical Operations for the Cure of Carcinoma of the Breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Karnofsky Memorial Lecture. Natural history of small breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Aging, progression, and phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Breast cancer screening with mammography: overview of Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Edinburgh trial of screening for breast cancer: mortality at seven years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

The benefits of mammography are not limited to women of ages older than 50 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Breast screening, prognostic factors and survival – results from the Swedish two county study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Clinical progression of breast cancer malignant behavior: what to expect and when to expect it

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Darwin's clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Nm23 and breast cancer metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

p53 protein and vimentin in invasive ductal NOS breast carcinoma--relationship with survival and sites of metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Vimentin--a new prognostic parameter in breast carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

The Biochemistry of Cancer Dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900151-9

7 January 2021

10.1016/S0959-8049(00)00151-9

Identifiers

DOI

1 reference

30 July 2017

1 reference